| Literature DB >> 30809323 |
Kin On Kwok1,2,3, Arthur Tang4, Vivian W I Wei1, Woo Hyun Park5, Eng Kiong Yeoh1, Steven Riley6.
Abstract
The emergence and reemergence of coronavirus epidemics sparked renewed concerns from global epidemiology researchers and public health administrators. Mathematical models that represented how contact tracing and follow-up may control Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) transmissions were developed for evaluating different infection control interventions, estimating likely number of infections as well as facilitating understanding of their likely epidemiology. We reviewed mathematical models for contact tracing and follow-up control measures of SARS and MERS transmission. Model characteristics, epidemiological parameters and intervention parameters used in the mathematical models from seven studies were summarized. A major concern identified in future epidemics is whether public health administrators can collect all the required data for building epidemiological models in a short period of time during the early phase of an outbreak. Also, currently available models do not explicitly model constrained resources. We urge for closed-loop communication between public health administrators and modelling researchers to come up with guidelines to delineate the collection of the required data in the midst of an outbreak and the inclusion of additional logistical details in future similar models.Entities:
Keywords: Co-V, Coronavirus; Contact Tracing; Coronavirus Epidemics; MERS; MERS, Middle East Respiratory Syndrome; R0, Basic reproduction number; SARS; SARS, Severe Acute Respiratory Syndrome; SEIR, Susceptible Exposed Infectious Recovered; Transmission Modelling; WHO, World Health Organization
Year: 2019 PMID: 30809323 PMCID: PMC6376160 DOI: 10.1016/j.csbj.2019.01.003
Source DB: PubMed Journal: Comput Struct Biotechnol J ISSN: 2001-0370 Impact factor: 7.271
Fig. 1Flow diagram of the selection process.
Summary of characteristics of the reviewed studies.
| Author | Lloyd Smith et al. | Fraser et al. | Becker et al. | Chen et al. | Klinkenberg et al. | Feng et al. | Peak et al. |
|---|---|---|---|---|---|---|---|
| Year | 2003 | 2004 | 2005 | 2006 | 2006 | 2009 | 2017 |
| Model type | Population based: Stochastic SEIR compartmental model | Agent based: Discrete time simulation model | Agent based: Branching process with household level transmission model | Population based: Von Foerster equation-based control model | Agent based: Discrete time simulation model | Population based: SEIR compartmental model | Agent based: SEIR compartmental branching model |
| Co-V to be studied | SARS | SARS | SARS | SARS | SARS | SARS | MERS and SARS |
| Setting | Community and its hospital | Community | Community of households | Hospital | Community | Community and | Community |
| Social contact structure | Homogeneous mixing | Homogeneous mixing | Heterogeneous mixing between two groups: school attendees and non-school attendees | Homogeneous mixing | Homogeneous mixing | Homogeneous mixing | Homogeneous mixing |
| Types of tracing | Single-step | Single-step | Single-step | Single-step | Single-step or Interactive | Single-step | Single-step |
| Self-reported limitations | 1. Superspreading event was not considered in the model. | Overestimation in contact tracing efficacy due to failure of identifying correlation structure between diseases generation by contact tracing. | The effect of different interventions on infection dynamics was not considered. | Transmission heterogeneity such as different social contact mixing was not considered in the model. | 1. The model only considers transmission before tracing or isolation. | 1. Medical consultation seeking rate and diagnosis probability were combined. | The study focused on early stage of the outbreak. |
Summary of key epidemiological parameters used in the reviewed studies.
| Author | Lloyd Smith et al. | Fraser et al. | Becker et al. | Chen et al. | Klinkenberg et al. | Feng et al. | Peak et al. |
|---|---|---|---|---|---|---|---|
| Year | 2003 | 2004 | 2005 | 2006 | 2006 | 2009 | 2017 |
| a) Basic reproduction number (Ro) | 1.5–5 | 2–4 | 6 | 0.25–5.31 | 1.5, 2 and 3 | Not an input parameter | 2.9 for SARS |
| b) Incubation period | Gamma distribution | Gamma distribution with mean of 4.25 days and variance of 14.25 days | Assumed to be equal to latent period | Exponential distribution | Gamma distribution with 3.81 days | Gamma distribution of incubation period was used for Latin Hypercube sampling | 4.01 days for SARS |
| c) Latent period | Not included in the model | Not included in the model | 6.5 days | Not included in the model | 6.81 days | Not included in the model | Represented by the latent offset term which refers to the timing of the latent period relative to the incubation period |
| d) Infectious period | Gamma distribution | Gamma distribution: | Effective infectious period of 9 days | Exponential distribution | Effective infectious period of 3.87 days | Gamma distribution of infectious period was used for Latin Hypercube sampling | Represented by time varying relative infectiousness following triangular distribution |
Fig. 2Disease progression periods in the natural history of a disease course. Note that symptom onset can occur before or after being infectious.
Summary of intervention parameters of the reviewed studies.
| Author | Lloyd Smith et al. | Fraser et al. | Becker et al. | Chen et al. | Klinkenberg et al. | Feng et al. | Peak et al. |
|---|---|---|---|---|---|---|---|
| Year | 2003 | 2004 | 2005 | 2006 | 2006 | 2009 | 2017 |
| a) Successful tracing ratio | Not included in the model | Not included in the model | Assuming 100% traced on all household members of the primary household infective and a proportion of 50% of between household contact of an infective | Yes; Not explicitly included in the model but reflected in contact tracing efficacy | Yes; named as probability of contact being traced | Not included in the model | Yes; named as proportion of contact traced; |
| b) Asymptomatic infection ratio | 0–10% | 0–11% | Not included in the model | 0.01–11% | Not included in the model | Yes; reflected in infection rates contributed by exposed individuals | Yes |
| c) Quarantine delay | Yes; probability of quarantining incubating individuals in community to reflect delay of quarantine of incubating individuals in the community | yes; | Not included in the model | Yes; in term of contact tracing efficacy | Not included in the model | Yes; a progression rate from exposed state to prodrome in the disease dynamics | Yes; by a term of delay in tracing a named contact |
| d) Isolation delay | Yes; in terms of “probability of isolation of symptomatic individuals in the community” and “probability of isolation of symptomatic health care workers” | Yes; in terms of a distribution characterizing an individual person who has not been isolated by time since infection to reflect all individuals' infection due to this delay | Yes; proportion of the infectious period that has passed at the time the infected is isolated. | Not included in the model | Yes; | Yes; | Yes; |
| e) Quarantine efficiency | Yes; in the term of “probability of quarantining of incubating individuals in the community” | Yes; defined as quarantine efficacy | Not included in the model; assuming 100% efficiency | Yes; in term of contact tracing efficacy | Not included in the model; | Yes; in terms of | Not included in the model; |
| f) Isolation efficiency | Yes; reflected in two terms: “probability of isolation of symptomatic individuals in the community” and “probability of isolation of symptomatic health care workers” | Yes; defined as isolation efficacy and contact tracing efficiency | Not included in the model; | Not included in the model; | Not included in the model; | Yes; in terms of a smaller hospitalization rate per capita of the symptomatic individuals | Yes; in terms of a term of isolation effectiveness |
| h) Correlation structure between diseases generation due to contact tracing | No | No | No | No | No | No | Yes |